Goldman Sachs’s Exact Sciences EXAS Stock Holding History

Goldman Sachs’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39,000	Closed	-$2.13M	–	6546
2025 Q3	$2.13M	Buy	+39,000	New	+$1.95M	﹤0.01%	4422
2024 Q2	–	Sell	-8,500	Closed	-$587K	–	5728
2024 Q1	$587K	Buy	+8,500	New	+$538K	﹤0.01%	4666
2022 Q1	–	Sell	-10,500	Closed	-$817K	–	6654
2021 Q4	$817K	Hold	10,500	–	–	﹤0.01%	5019
2021 Q3	$1M	Buy	+10,500	New	+$1.11M	﹤0.01%	4737
2021 Q1	–	Sell	-84,300	Closed	-$11.2M	–	6146
2020 Q4	$11.2M	Hold	84,300	–	–	﹤0.01%	2369
2020 Q3	$8.59M	Buy	+84,300	New	+$7.28M	﹤0.01%	2450
2020 Q2	–	Sell	-355,600	Closed	-$20.6M	–	5283
2020 Q1	$20.6M	Buy	355,600 +306,100	+618%	+$24.9M	0.01%	1482
2019 Q4	$4.58M	Buy	+49,500	New	+$4.35M	﹤0.01%	3030
2019 Q1	–	Sell	-23,300	Closed	-$1.47M	–	5220
2018 Q4	$1.47M	Buy	+23,300	New	+$1.6M	﹤0.01%	3730
2018 Q3	–	Sell	-9,000	Closed	-$538K	–	5629
2018 Q2	$538K	Sell	9,000 -60,000	-87%	-$3.23M	﹤0.01%	4463
2018 Q1	$2.78M	Sell	69,000 -12,400	-15%	-$605K	﹤0.01%	3346
2017 Q4	$4.28M	Buy	81,400 +41,400	+104%	+$2.21M	﹤0.01%	3145
2017 Q3	$1.89M	Sell	40,000 -146,000	-78%	-$5.88M	﹤0.01%	4053
2017 Q2	$6.58M	Buy	186,000 +121,000	+186%	+$3.73M	﹤0.01%	2839
2017 Q1	$1.53M	Buy	+65,000	New	+$1.29M	﹤0.01%	4009
2016 Q4	–	Sell	-17,700	Closed	-$329K	–	6936
2016 Q3	$329K	Sell	17,700 -48,200	-73%	-$849K	﹤0.01%	5404
2016 Q2	$807K	Buy	+65,900	New	+$496K	﹤0.01%	4392
2015 Q4	–	Sell	-132,500	Closed	-$2.38M	–	7212
2015 Q3	$2.38M	Buy	132,500 +37,400	+39%	+$859K	﹤0.01%	3617
2015 Q2	$2.83M	Sell	95,100 -14,900	-14%	-$374K	﹤0.01%	3498
2015 Q1	$2.42M	Sell	110,000 -20,000	-15%	-$507K	﹤0.01%	3589
2014 Q4	$3.57M	Sell	130,000 -79,900	-38%	-$1.94M	﹤0.01%	3291
2014 Q3	$4.07M	Buy	+209,900	New	+$3.85M	﹤0.01%	3217
2014 Q2	–	Sell	-859,200	Closed	-$12.2M	–	7027
2014 Q1	$12.2M	Buy	+859,200	New	+$11.6M	﹤0.01%	2185

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Goldman Sachs's EXAS Position: Q1 2026 in Review

Goldman Sachs sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,410,459 shares — an estimated $143M sold.

Goldman Sachs first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $143M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Goldman Sachs reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Goldman Sachs sold 1,410,459 Exact Sciences shares in Q1 2026, an estimated $143M.
Goldman Sachs first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
Goldman Sachs's Exact Sciences position peaked at $143M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.